88
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD

, , , , , , & show all
Pages 1689-1703 | Published online: 27 Jul 2016

References

  • DewarMCurryRWJrChronic obstructive pulmonary disease: diagnostic considerationsAm Fam Physician200673466967616506711
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPDBethesda (MD)GOLD2014
  • HoogendoornMFeenstraTLHoogenveenRTAlMMolkenMRAssociation between lung function and exacerbation frequency in patients with COPDInt J Chron Obstruct Pulmon Dis2010543544421191438
  • JonesPWHealth status measurement in chronic obstructive pulmonary diseaseThorax2001561188088711641515
  • SolemCTSunSXLiuSComparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient surveyInt J Chron Obstruct Pulmon Dis2014999199825284999
  • WestwoodMBourbeauJJonesPWCerulliACapkun-NiggliGWorthyGRelationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic reviewRespir Res2011124021477298
  • AnzuetoALeimerIKestenSImpact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomesInt J Chron Obstruct Pulmon Dis2009424525119657398
  • GroenewegenKHPostmaDSHopWCIncreased systemic inflammation is a risk factor for COPD exacerbationsChest2008133235035718198263
  • GudmundssonGGislasonTJansonCRisk factors for rehospitalisation in COPD: role of health status, anxiety and depressionEur Respir J200526341441916135721
  • GudmundssonGGislasonTLindbergEMortality in COPD patients discharged from hospital: the role of treatment and co-morbidityRespir Res2006710916914029
  • JonesPWDonohueJFNedelmanJPascoeSPinaultGLassenCCorrelating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysisRespir Res20111216122206353
  • ManninoDMDavisKJLung function decline and outcomes in an elderly populationThorax200661647247716517577
  • McGloneSVennAWaltersEHWood-BakerRPhysical activity, spirometry and quality-of-life in chronic obstructive pulmonary diseaseCOPD200632838817175670
  • NiewoehnerDERelation of chronic obstructive pulmonary disease exacerbations to FEV(1) – an intricate tangoRespiration200977222923518840996
  • OmataMWakabayashiRKudohSKidaKCorrelation between bronchodilator responsiveness and quality of life in chronic obstructive pulmonary diseaseAllergol Int2007561152217259805
  • SeemungalTADonaldsonGCBhowmikAJeffriesDJWedzichaJATime course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016151608161310806163
  • YuAPYangHWuEQSetyawanJMocarskiMBlumSIncremental third-party costs associated with COPD exacerbations: a retrospective claims analysisJ Med Econ201114331532321500975
  • JanssonSAAnderssonFBorgSEricssonAJönssonELundbäckBCosts of COPD in Sweden according to disease severityChest200212261994200212475838
  • JanssonSABackmanHStenlingALindbergARönmarkELundbäckBHealth economic costs of COPD in Sweden by disease severity – has it changed during a ten years period?Respir Med2013107121931193823910072
  • ChungKKimKJungJPatterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in KoreaBMC Pulm Med2014142724571796
  • DiezJMGarridoPCCarballoMGDeterminants and predictors of the cost of COPD in primary care: a Spanish perspectiveInt J Chron Obstruct Pulmon Dis20083470171219281084
  • HillemanDEDewanNMaleskerMFriedmanMPharmacoeconomic evaluation of COPDChest200011851278128511083675
  • KolevaDMortterliniNBanfiPGarattiniLHealthcare costs of COPD in Italian referral centres: a prospective studyRespir Med2007101112312232017681461
  • LacasseYDaigleJMMartinSKMaltaisFValidity of chronic obstructive pulmonary disease diagnoses in a large administrative databaseCan Respir J2012192e5e922536584
  • Maleki-YazdiMKellySMLamSSMarinMBarbeauMWalkerVThe burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in CanadaCan Respir J201219531932423061077
  • MapelDWMcMillanGPFrostFJPredicting the costs of managing patients with chronic pulmonary diseaseRespir Med200599101325133316140232
  • MapelDWRobertsMSpirometry, the St. George’s Respiratory Questionnaire, and other clinical measures as predictors of medical costs and COPD exacerbation events in a prospective cohortSouthwest Respir Crit Care Chron201531019
  • MennPHeinrichJHuberRMDirect medical costs of COPD – an excess cost approach based on two population-based studiesRespir Med2012106454054822100535
  • MiravitllesMMurioCGuerreroTGisbertRCosts of chronic bronchitis and COPD: a 1-year follow-up studyChest2003123378479112628879
  • NielsenRJohannessenAOmenaasERBakkePSAskildsenJEGulsvikAExcessive costs of COPD in ever-smokers: a longitudinal community studyRespir Med2011105348549321030232
  • QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care200543111130113916224307
  • Bureau of Labor StatisticsDatabases, tables & calculators by subject Available from: http://data.bls.gov/timeseries/CUUR0000SAM?output_view=pct_12mthsAccessed September 10, 2015
  • ManninoDMGagnonRCPettyTLLydickEObstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994Arch Intern Med2000160111683168910847262
  • LouieSZekiAASchivoMThe asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerationsExpert Rev Clin Pharmacol20136219721923473596
  • McDonaldVMSimpsonJLHigginsIGibsonPGMultidimensional assessment of older people with asthma and COPD: clinical management and health statusAge Ageing2011401424921087988
  • SorianoJBDavisKJColemanBVisickGManninoDPrideNBThe proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United KingdomChest2003124247448112907531
  • BakerCLZouKHSuJRisk assessment of readmissions following an initial COPD-related hospitalizationInt J Chron Obstruct Pulmon Dis2013855155924348031
  • BlasiFCesanaGContiSThe clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patientsPLoS One201496e10122824971791
  • FanVSRamseySDMakeBJMartinezFJPhysiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPDCOPD200741293917364675
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • SuissaSDell’AnielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
  • AaronSDManagement and prevention of exacerbations of COPDBMJ2014349g523725245156
  • AgustiACalverleyPMDecramerMStockleyRAWedzichaJAPrevention of exacerbations in chronic obstructive pulmonary disease: knowns and unknownsChronic Obstr Pulm Dis (Miami)201412166184
  • DecramerMLChapmanKRDahlROnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med20131752453324461613
  • VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
  • DrivenesEOstremAMelbyeHPredictors of ICS/LABA prescribing in COPD patients: a study from general practiceBMC Fam Pract2014154224597538